Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1

Overview of attention for article published in Frontiers in Pharmacology, November 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Readers on

mendeley: 14 Mendeley

Summary News X

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 7,588 followers.

Weichang019an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer014Making ... https://t.co/a7QSdmjc3O

13 Dec 2021

Reply Repost Favourite

Weichang019an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer014Making ... https://t.co/a7QSdmjc3O

30 Sep 2021

Reply Repost Favourite

New article: Weichang'an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer-Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1 https://t.co/GHrSSenjnc #colorectalcancer #oncology https://t.co/hL8v

22 Mar 2021

Reply Repost Favourite

New Research: Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1 https://t.co/Vke5ZLLiY3 #pharmacology

04 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.